Table 4.
Bivariate analysis of demographic and clinical characteristics between inadequately controlled and controlled patients
| Variable | Inadequate control (n = 625) | Controlled (n = 439) | P |
|---|---|---|---|
| Age, years | 40.0 ±16.4 | 40.7 ±15.5 | 0.2691 |
| Race, n (%) | |||
| White/Caucasian | 441 (70.6) | 359 (82.3) | <0.0001* |
| Non‐white/Caucasian | 184 (29.4) | 80 (18.3) | |
| African American | 88 (14.1) | 42 (9.6) | |
| Hispanic/Latino | 49 (7.8) | 16 (3.6) | |
| Other | 47 (7.5) | 22 (5.0) | |
| Sex, n (%) | 0.1512 | ||
| Male | 279 (44.6) | 216 (49.2) | |
| Female | 346 (55.4) | 223 (50.8) | |
| Employment status, n (%)† | 0.2677 | ||
| Unemployed | 127 (20.8) | 77 (17.9) | |
| Employed | 484 (79.2) | 352 (82.1) | |
| Body mass index, n (%) | 0.0843 | ||
| Normal (18.5–24.9 kg/m2) | 273 (43.9) | 159 (36.3) | |
| Overweight (25.0–29.9 kg/m2) | 236 (37.9) | 203 (46.3) | |
| Obese (≥30 kg/m2) | 113 (18.2) | 76 (17.4) | |
| Head and neck currently affected, n (%) | 283 (45.3) | 141 (32.1) | <0.0001 |
| Upper limbs currently affected, n (%) | 498 (79.7) | 346 (78.8) | 0.7586 |
| Trunk currently affected, n (%) | 379 (60.6) | 225 (51.3) | 0.0026 |
| Lower limbs currently affected, n (%) | 424 (67.8) | 269 (61.3) | 0.0310 |
| EASI score | 10.4 ± 9.9 | 7.8 ± 6.7 | <0.0001 |
| BSA affected, % | 16.5 ± 15.8 | 14.0 ± 11.0 | 0.2794 |
| No. of flares in last 12 months | 2.5 ± 2.0‡ | 1.3 ± 1.7§ | <0.0001 |
| No. of baseline symptoms (day‐to‐day) | 4.9 ± 4.7¶ | 5.9 ± 3.5 | <0.0001 |
| No. of other atopic conditions | 1.2 ± 1.2†† | 1.0 ± 1.0‡‡ | 0.0175 |
| Charlson Comorbidity Index | 0.2 ± 0.6 | 0.1 ± 0.6 | 0.4882 |
*P‐value for non‐Hispanic white versus all others; P = 0.0003 when comparing all racial groups. †Non‐missing data n = 611 for inadequate control group and n = 429 for controlled group. ‡ n = 476, § n = 407, ¶ n = 592, †† n = 572, ‡‡ n = 408. Data are presented as mean ± standard deviation unless otherwise stated. BSA, body surface area; EASI, Eczema Area and Severity Index.